These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27115262)

  • 1. A Patient-Designed Do-It-Yourself Mobile Technology System for Diabetes: Promise and Challenges for a New Era in Medicine.
    Lee JM; Hirschfeld E; Wedding J
    JAMA; 2016 Apr; 315(14):1447-8. PubMed ID: 27115262
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient Inputs for Mobile Health Systems for Type 1 Diabetes Care.
    Kerr D; Axelrod C; Hoppe C
    Diabetes Technol Ther; 2017 Apr; 19(4):201-202. PubMed ID: 28418730
    [No Abstract]   [Full Text] [Related]  

  • 3. Evolution of Do-It-Yourself Remote Monitoring Technology for Type 1 Diabetes.
    Ng M; Borst E; Garrity A; Hirschfeld E; Lee J
    J Diabetes Sci Technol; 2020 Sep; 14(5):854-859. PubMed ID: 31893941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA Advisory Panel Votes to Recommend Non-Adjunctive Use of Dexcom G5 Mobile CGM.
    Diabetes Technol Ther; 2016 Aug; 18(8):512-6. PubMed ID: 27472488
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuous glucose monitoring in the management of diabetes mellitus.
    McGahan L
    Issues Emerg Health Technol; 2002 May; (32):1-4. PubMed ID: 12096755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-Driven Diabetes Technologies: Sentiment and Personas of the #WeAreNotWaiting and #OpenAPS Movements.
    Litchman ML; Walker HR; Fitzgerald C; Gomez Hoyos M; Lewis D; Gee PM
    J Diabetes Sci Technol; 2020 Nov; 14(6):990-999. PubMed ID: 32627587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous glucose monitoring and type 1 diabetes.
    Montagnana M; Lippi G; Guidi GC
    N Engl J Med; 2009 Jan; 360(2):190; author reply 191-2. PubMed ID: 19129536
    [No Abstract]   [Full Text] [Related]  

  • 8. [Importance of continuous measurement of glycemia].
    Riveine JP
    Soins; 2009 May; (735):24, 26, 28. PubMed ID: 19485177
    [No Abstract]   [Full Text] [Related]  

  • 9. First application of a transcutaneous optical single-port glucose monitoring device in patients with type 1 diabetes mellitus.
    Rumpler M; Mader JK; Fischer JP; Thar R; Granger JM; Deliane F; Klimant I; Aberer F; Sinner F; Pieber TR; Hajnsek M
    Biosens Bioelectron; 2017 Feb; 88():240-248. PubMed ID: 27554063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DAILY (Daily Automated Intensive Log for Youth) trial: a wireless, portable system to improve adherence and glycemic control in youth with diabetes.
    Kumar VS; Wentzell KJ; Mikkelsen T; Pentland A; Laffel LM
    Diabetes Technol Ther; 2004 Aug; 6(4):445-53. PubMed ID: 15320998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to Glucose Testing and Attitudes Toward Mobile App and Device Use in a Large Cohort of T1D Pediatric Patients: Implications for Diabetes Management.
    Barnes TL; Lee S; Thompson N; Mullen K; Chatterton P; Gandrud L
    J Diabetes Sci Technol; 2018 Nov; 12(6):1246-1247. PubMed ID: 30136595
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): Is CGM ready for real time?
    Mazze RS; Strock E; Borgman S; Wesley D; Stout P; Racchini J
    Diabetes Technol Ther; 2009 Jan; 11(1):11-8. PubMed ID: 19132850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World Use and Self-Reported Health Outcomes of a Patient-Designed Do-it-Yourself Mobile Technology System for Diabetes: Lessons for Mobile Health.
    Lee JM; Newman MW; Gebremariam A; Choi P; Lewis D; Nordgren W; Costik J; Wedding J; West B; Gilby NB; Hannemann C; Pasek J; Garrity A; Hirschfeld E
    Diabetes Technol Ther; 2017 Apr; 19(4):209-219. PubMed ID: 28245152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous glucose monitoring in normal mice and mice with prediabetes and diabetes.
    Klueh U; Liu Z; Cho B; Ouyang T; Feldman B; Henning TP; Kaur M; Kreutzer D
    Diabetes Technol Ther; 2006 Jun; 8(3):402-12. PubMed ID: 16800762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wireless Monitoring for Patients with Cardiovascular Diseases and Parkinson's Disease.
    Kefaliakos A; Pliakos I; Charalampidou M; Diomidous M
    Stud Health Technol Inform; 2016; 226():87-90. PubMed ID: 27350473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA Approval of Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing: A Potentially Risky Decision.
    Shapiro AR
    JAMA; 2017 Oct; 318(16):1541-1542. PubMed ID: 28910454
    [No Abstract]   [Full Text] [Related]  

  • 17. New features and performance of a next-generation SEVEN-day continuous glucose monitoring system with short lag time.
    Bailey T; Zisser H; Chang A
    Diabetes Technol Ther; 2009 Dec; 11(12):749-55. PubMed ID: 20001675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closing the loop: the adicol experience.
    Hovorka R; Chassin LJ; Wilinska ME; Canonico V; Akwi JA; Federici MO; Massi-Benedetti M; Hutzli I; Zaugg C; Kaufmann H; Both M; Vering T; Schaller HC; Schaupp L; Bodenlenz M; Pieber TR
    Diabetes Technol Ther; 2004 Jun; 6(3):307-18. PubMed ID: 15198833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WEARABLES, IMPLANTS AND APPS, Oh My! SMART TECHNOLOGY FOR DIABETES SELF-CARE.
    Davies N
    Diabetes Self Manag; 2016; 33(2):28-31. PubMed ID: 27086397
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems.
    Garg SK; Smith J; Beatson C; Lopez-Baca B; Voelmle M; Gottlieb PA
    Diabetes Technol Ther; 2009 Feb; 11(2):65-72. PubMed ID: 19243265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.